Physician profile
Steven E Sckolnik
NPI 1881956894
$9,794.95
in general payments reported to CMS, 2019-2025
26 companies · $977 in 2025
The $977 reported for 2025 was more than what 83% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $245 · 2021: $102 · 2022: $1,440 · 2023: $1,639 · 2024: $5,100 · 2025: $977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,635 · Consulting Fee: $2,100 · Food and Beverage: $1,948 · Entertainment: $33.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,634.52 |
| Consulting Fee | $2,100.00 |
| Food and Beverage | $1,947.60 |
| Entertainment | $33.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $5,462.63 | 2022-2025 | Gammatile, Gammatile |
| Astrazeneca Pharmaceuticals LP | $2,100.00 | 2024 | Imfinzi, Tagrisso |
| Elekta, INC. | $244.97 | 2020 | |
| Icotec Medical INC. | $213.67 | 2022 | |
| Intuitive Surgical, INC. | $195.68 | 2022-2025 | |
| Steris Corporation | $185.97 | 2023 | |
| Progenics Pharmaceuticals, INC. | $157.08 | 2022-2025 | Pylarify |
| Advanced Accelerator Applications | $148.09 | 2019 | |
| Varian Medical Systems, INC. | $144.14 | 2019 | |
| Pfizer INC. | $120.43 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $102.12 | 2021 | |
| Sobi, INC | $75.43 | 2024 | |
| Tactile Systems Technology INC | $75.01 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Daiichi Sankyo INC. | $74.05 | 2022-2025 | Enhertu, Datroway |
| Siemens Medical Solutions USA, INC. | $66.67 | 2024 | Halcyon |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $65.58 | 2024 | |
| Abbvie INC. | $49.73 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $46.18 | 2022-2025 | |
| Incyte Corporation | $44.19 | 2022-2025 | Monjuvi, Zynyz |
| Merck Sharp & Dohme LLC | $43.89 | 2022-2025 | Keytruda |
| Argentum Medical | $33.51 | 2024 | |
| Ge Healthcare | $32.55 | 2025 | |
| Blue Earth Diagnostics | $31.75 | 2024 | |
| Novocure INC. | $30.64 | 2023 | Optune |
| Janssen Biotech, INC. | $29.77 | 2025 | Carvykti, Darzalex, Tecvayli |
| Boston Scientific Corporation | $21.22 | 2025 | Spaceoar Vue System - 10ml |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Sckolnik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.